Cuprous oxide nanoparticles (Cu 2 O NPs) were dispersed into a graphene oxide (GO) solution to form a homogeneous Cu 2 O-GO dispersion. After this, the cuprous oxide nanoparticles were functionalized to electrochemically reduce the graphene oxide decorated glassy carbon electrode (Cu 2 O-ErGO/GCE). This was prepared by coating the Cu 2 O-GO dispersion onto the surface of the glassy carbon electrode (GCE), which was followed by a potentiostatic reduction process. An irreversible two-electron reaction of uric acid (UA) was observed at the voltammetric sensor. Moreover, the high concentrations of dopamine (DA) and ascorbic acid (AA) hardly affected the peak current of UA, which suggested that Cu 2 O-ErGO/GCE have excellent selectivity for UA. This is probably because the response peaks of the three compounds are well-separated from each other. The oxidation peak current was proportional to the concentration of UA in the ranges of 2.0 nM−0.6 µM and 0.6 µM−10 µM, respectively, with a low limit of detection (S/N = 3, 1.0 nM) after an accumulation time of 120 s. Cu 2 O-ErGO/GCE was utilized for the rapid detection of UA in human blood serum and urine samples with satisfactory results. when detecting UA with bare electrodes since they have similar oxidation peak potentials [10][11][12]. Nanocomposite-modified electrodes can improve the anti-interference performance and selectivity, which is a common method that is used to solve this problem. At present, many chemically modified electrodes have been proposed for the determination of UA [9,[13][14][15][16][17][18][19][20][21][22] although their selectivity is limited, especially due to the coexistence of DA and AA. Hence, developing a modified electrode with high sensitivity and selectivity to meet clinical demands is still challengeable and desirable.Catalysts 2018, 8, x FOR PEER REVIEW 2 of 15 potentials [10][11][12]. Nanocomposite-modified electrodes can improve the anti-interference performance and selectivity, which is a common method that is used to solve this problem. At present, many chemically modified electrodes have been proposed for the determination of UA [9,[13][14][15][16][17][18][19][20][21][22] although their selectivity is limited, especially due to the coexistence of DA and AA. Hence, developing a modified electrode with high sensitivity and selectivity to meet clinical demands is still challengeable and desirable. Scheme 1. The reaction mechanism of UA.In the past few years, transition metals and metal oxides have received increasing attention in many fields, such as sensors and electrocatalysis, due to their unique sensing performance and superior electrocatalytic activity [9,11,23,24]. Among these metal oxides, cuprous oxide (Cu2O) is a new type of p-type semiconductor with a narrow band gap, which can also be easily excited by visible light. Due to their outstanding advantages, such as non-toxic, low cost and stable photochemical properties, Cu2O nanoparticles have been extensively used in many fields, such as new energy, photocatalytic degradation, ...